CTOs on the Move

PharmMD

www.pharmmd.com

 
At PharmMD, we believe every patient deserves personalized attention, the best information available, and reliable guidance from medical professionals to live a healthier life. This deeply held conviction guided our founder Fred McWhorter, an old-fashioned pharmacist who devoted more than 50 years to his passion of bringing health and healing to his customers–not simply selling medicine. Recognizing the value of emerging technology, he envisioned building a real-time information bridge between pharmacists (Pharm) and physicians (MD) to significantly improve patient treatment. Following Fred’s untimely death in 2005, his brother Clayton McWhorter, a veteran healthcare pioneer, brought Fred’s dream to fruition. In 2006, Clayton ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pharmmd.com
  • 5200 Maryland Way Suite 200
    Brentwood, TN USA 37027
  • Phone: 615.346.0880

Executives

Name Title Contact Details

Similar Companies

Inimex Pharmaceuticals

Inimex Pharmaceuticals Inc. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Basic Research

Basic Research, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

U.S. Urology Partners

U.S. Urology Partners is a physician-led management services organization that provides business support services to our network of urology practices .

Vishnu Chemicals Limited

Vishnu Chemicals Limited is a Eatontown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reset Therapeutics

Reset Therapeutics is a biopharmaceutical company formed to discover, develop and commercialize new therapeutics that modulate the circadian system, the body`s network of internal molecular clocks. The circadian system synchronizes behavioral and physiological processes, including sleep, metabolism, feeding, blood pressure and hormone secretion with the environmental cycles of light, activity and nutrient status. Disruption of normal circadian rhythms is associated with many diseases, including central nervous system, cardiovascular and metabolic disorders, immune system dysfunction and cancer. Novel therapies that reset the body’s biological clocks have the potential to benefit very large and diverse patient populations